Parmax Pharma Ltd Share Price History : Returns Comparison, Growth Analysis

Home

Insights

History

Parmax Pharma Ltd Share Price History

₹ 0.0 Cr

Volume transacted

2.4 K

stocks traded

Last Updated time: 17 Sep 13:45 PM

Parmax Pharma Ltd

BSE

17 Sep, 2024

44.20.0 (0.0%)

Prev Close

44.2

Open Price

45.9

Bid Price (QTY)

45.9 (0)

Offer Price (QTY)

44.2 (0)

Volume

2363

Today's High / Low

46.4 / 44.2

52 WK High / Low

47.8 / 24.2

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

To make informed investment decisions, regularly checking Parmax Pharma Ltd share price can be a beneficial practice. *All values are in Rupees.

Last Ten Days Share Price

Date	Price	Day Open	Day High	Day Low

16 Sep 2024	44.2	44.2	44.2	42
13 Sep 2024	42.1	42.39	42.39	39.05
12 Sep 2024	40.55	40.5	40.79	36.91
11 Sep 2024	38.85	36.3	38.85	36.3
10 Sep 2024	37	37	37	36
09 Sep 2024	35.25	35.8	36.11	34.1
06 Sep 2024	35.05	34.5	35.17	33
05 Sep 2024	33.5	34	34.65	33.5
04 Sep 2024	33	34	35.5	33
03 Sep 2024	34	35.7	35.71	34

Date	Price
16 Sep 2024	44.2
13 Sep 2024	42.1
12 Sep 2024	40.55
11 Sep 2024	38.85
10 Sep 2024	37
09 Sep 2024	35.25
06 Sep 2024	35.05
05 Sep 2024	33.5
04 Sep 2024	33
03 Sep 2024	34

Returns Comparison

10Y

Returns Comparison Table

Entity	1W	1M	3M	6M	1Y	3Y	5Y	10Y

Cipla Ltd	2.4	5.3	5.4	11.6	33.8	74.0	252.8	167.8
Torrent Pharmaceuticals Ltd	0.8	3.2	19.6	34.5	83.2	121.9	303.9	679.1
Sun Pharmaceuticals Industries Ltd	2.3	6.9	22.5	18.5	62.3	138.6	336.6	133.5
Parmax Pharma Ltd	25.4	32.9	41.4	43.6	38.6	7.0	143.5	253.6
Zydus Lifesciences Ltd	1.0	-6.0	3.4	12.6	73.4	97.7	361.0	338.4
Divis Laboratories Ltd	5.9	18.2	20.1	56.3	44.8	6.1	233.1	555.1

Entity	1W
Cipla Ltd	2.4
Torrent Pharmaceuticals Ltd	0.8
Sun Pharmaceuticals Industries Ltd	2.3
Parmax Pharma Ltd	25.4
Zydus Lifesciences Ltd	1.0
Divis Laboratories Ltd	5.9

Last updated time: 17 Sep 13:45 PM

Growth Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023

Sales	-	12	12	21	26	18	15
Sales YoY Gr.	-	1190.0%	0.9%	74.3%	25.2%	-30.3%	-15.5%
Adj EPS	0	0	0.18	0.96	1.69	0.32	-0.23
YoY Gr.	-	0.0%	18.0%	433.3%	76.0%	-81.1%	-171.9%
Adj Net Profit	-0	-	-	-	1	-	-0
BVPS	10.24	10.24	10.41	11.38	13.07	13.39	13.16

Parameter	2017
Sales	0
Sales YoY Gr.	-
Adj EPS	0
YoY Gr.	-
Adj Net Profit	-0
BVPS	10.24

Key Financial Parameters

Parameter	2017	2018	2019	2020	2021	2022	2023

Return on Capital Emp. %	0	0.66	1.56	8.4	14.26	6.04	4.03
Op. Profit Mgn %	0	9.5	9.66	8.93	13.44	14.41	15.05
Net Profit Mgn %	0	0	0.67	2.05	2.86	0.77	-0.65
Debt to Equity %	0.16	0.33	0.82	1.11	1.02	0.94	0.89

Parameter	2017
Return on Capital Emp. %	0
Op. Profit Mgn %	0
Net Profit Mgn %	0
Debt to Equity %	0.16

Latest Shareholding

No data available

Promoters Holdings Over Time

No data available

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations.
The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

Check out other companies share price history

Sun Pharmaceuticals Industries Ltd

Sun Pharmaceutical Industries Limited including its subsidiaries and associates ...

Divis Laboratories Ltd

Divi's Laboratories Ltd. is one of the leading pharmaceutical companies in the w...

Cipla Ltd

The Company is in the business of manufacturing, developing, and marketing wide ...

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited, the flagship Company of the Torrent Group, is o...

Zydus Lifesciences Ltd

The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadoda...

Popular Search

Parmax Pharma Ltd dividend

Parmax Pharma Ltd pe ratio

Parmax Pharma Ltd market cap

Parmax Pharma Ltd financials

Sun Pharmaceuticals Industries Ltd share price history

Divis Laboratories Ltd share price history

Cipla Ltd share price history

Torrent Pharmaceuticals Ltd share price history

Zydus Lifesciences Ltd share price history

Dr Reddys Laboratories Ltd share price history

Lupin Ltd share price history

Mankind Pharma Ltd share price history

Aurobindo Pharma Ltd share price history

Alkem Laboratories Ltd share price history

FAQs for of Parmax Pharma Ltd

What factors influence the share price of Parmax Pharma Ltd over time?

The share price of Parmax Pharma Ltd is influenced by factors such as the company's financial performance, including earnings and revenue, as well as broader economic conditions and market trends. Furthermore, developments in the industry, regulatory changes, and geopolitical events can also impact the share price over time.

What are the key events that typically impact Parmax Pharma Ltd's share price history?

Key events that impact Parmax Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.

How do stock splits affect Parmax Pharma Ltd's share price history?

Stock splits reduce the nominal price of Parmax Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.

How do dividends impact the share price history of Parmax Pharma Ltd?

Dividends can influence Parmax Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.

How do corporate announcements affect Parmax Pharma Ltd’s share price history?

Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Parmax Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.

How can I use technical analysis to understand Parmax Pharma Ltd’s share price history?

To understand Parmax Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*